Perrigo Company (
) will begin trading ex-dividend on November 26, 2013. A cash
dividend payment of $0.09 per share is scheduled to be paid on
December 17, 2013. Shareholders who purchased PRGO stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This marks the 5th quarter that PRGO has paid the same dividend. At
the current stock price of $155.28, the dividend yield is .23%.
The previous trading day's last sale of PRGO was $155.28,
representing a -0.53% decrease from the 52 week high of $156.10 and
a 57.18% increase over the 52 week low of $98.79.
PRGO is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). PRGO's current earnings per share, an indicator of a company's
profitability, is $4.73. Zacks Investment Research reports PRGO's
forecasted earnings growth in 2014 as 17.69%, compared to an
industry average of 7.1%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to PRGO through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PRGO as a top-10 holding:
- Market Vectors Israel ETF (
- SPDR S&P Pharmaceuticals ETF (
- iShares U.S. Pharmaceutical ETF (
- Guggenheim S&P 500 Equal Weight Healthcare ETF (
The top-performing ETF of this group is XPH with an increase of
23.58% over the last 100 days. ISRA has the highest percent
weighting of PRGO at 9.82%.